UnitedHealth lifts 2026 profit outlook on tighter medical cost controls
Optum’s operating income surge and improved Medicare cost ratios drive revised forecast, though the company anticipates significant Obamacare disenrollments next year.
UnitedHealth Group has raised its 2026 adjusted profit per share forecast to a range of $19.50 to $20.00, an increase from its previous guidance of at least $17.75. The revision follows a strong second-quarter performance where the company reported adjusted earnings of $6.38 per share, significantly surpassing the average analyst estimate of $4.90. Following the announcement, UnitedHealth’s shares rose nearly 5% in pre-market trading.
Chief Financial Officer Wayne DeVeydt attributed the improved results to effective cost controls within the Medicare health insurance business and increased payments for Medicaid plans serving low-income Americans. The company reported a second-quarter medical cost ratio of 86.70%, which beat analyst estimates of 88.47% and marked an improvement from the 89.4% recorded in the same period last year. DeVeydt noted that insurance plan design changes and new product pricing contributed to this reduction in costs.
The health services division, Optum, played a pivotal role in the financial results, with second-quarter operating income increasing 29% year-on-year to $4 billion. This performance reversed a 15% decline in operating income seen in the first quarter. The growth was driven by improved operations in the technology segment, Optum Insight, and better access to care within its clinical unit.
Despite the positive financial outlook, UnitedHealth anticipates challenges in the individual insurance market. The company expects 500,000 people to disenroll from Affordable Care Act, or Obamacare, plans in 2026. DeVeydt cited higher insurance costs and the expiration of extra pandemic-era government subsidies as the primary drivers for this projected membership decline.
UnitedHealth maintained its overall 2026 revenue outlook at $439 billion. The company also highlighted the impact of artificial intelligence tools introduced this year, which DeVeydt stated have reduced administrative burdens and allowed clinicians more time for patient treatment. He described the recovery of Optum Health as a multi-year journey, noting the company is ahead of schedule with full revenue growth expected by 2028.
